Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (7): 701-704    DOI: 10.19485/j.cnki.issn2096-5087.2025.07.012
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
舟山市带状疱疹首诊病例特征分析
冷雪1, 傅淑琴2, 舒纪为3, 谭启龙3, 李科峰4
1.舟山医院,浙江 舟山 316000;
2.岱山县中医院,浙江 岱山 316200;
3.岱山县疾病预防控制中心,浙江 岱山 316200;
4.舟山市疾病预防控制中心,浙江 舟山 316000
Characteristics of the first-visit cases of herpes zoster in Zhoushan City
LENG Xue1, FU Shuqin2, SHU Jiwei3, TAN Qilong3, LI Kefeng4
1. Zhoushan Hospital, Zhoushan, Zhejiang 316000, China;
2. Daishan County Hospital of Traditional Chinese Medicine, Daishan, Zhejiang 316200, China;
3. Daishan County Center for Disease Control and Prevention, Daishan, Zhejiang 316200, China;
4. Zhoushan Center for Disease Control and Prevention, Zhoushan, Zhejiang 316000, China
全文: PDF(802 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2021—2023年浙江省舟山市带状疱疹首诊病例特征,为完善带状疱疹防制措施提供参考。方法 通过舟山市全民健康信息平台和舟山市免疫规划信息管理系统收集2021—2023年舟山市各级公立医疗机构带状疱疹首诊病例发病和疫苗接种资料,计算发病率和门诊比例,描述性分析带状疱疹首诊病例的人群分布、季节分布和临床就诊情况。结果 2021—2023年舟山市报告带状疱疹首诊病例15 156例,年均发病率为5.36‰;各年份发病率分别为5.78‰、5.29‰和5.02‰,门诊比例分别为0.15%、0.14%和0.11%,呈下降趋势(均P<0.05);接种重组带状疱疹疫苗或带状疱疹减毒活疫苗分别为130、312和633剂次。就诊科室主要为皮肤科,11 004例占72.60%;临床诊断主要为内脏带状疱疹,5 901例占38.94%;至少有1种基础性疾病1 936例,占12.77%。发病年龄为(56.08±16.23)岁,发病率随年龄增长呈上升趋势(P<0.05)。男性7 386例,女性7 770例,男女比为0.95∶1;≥50岁男性发病率为6.53‰,低于女性的8.69‰(P<0.05)。发病有明显季节性,高峰期为6月21日—8月21日,覆盖75%病例。结论 2021—2023年舟山市带状疱疹发病率和门诊比例下降,夏季是发病高峰,女性和老年人是重点人群;建议加强皮肤科等重点科室的协同诊疗能力,提高重点人群预防接种积极性。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
冷雪
傅淑琴
舒纪为
谭启龙
李科峰
关键词 带状疱疹发病率预防接种    
AbstractObjective To analyze the characteristics of first-visit cases of herpes zoster in Zhoushan City, Zhejiang Province from 2021 to 2023, so as to provide the reference for improving herpes zoster prevention and control measures. Methods Data on the incidence and vaccination of first-visit herpes zoster cases at all levels of public medical institutions in Zhoushan City from 2021 to 2023 were collected through the Zhoushan Comprehensive Health Information Platform and Zhoushan Immunization Program Information Management System. The incidence and outpatient proportion were calculated. The population distribution, seasonal distribution, and clinical consultation status of first-visit herpes zoster cases were described. Results From 2021 to 2023, a total of 15 156 first-visit herpes zoster cases were reported in Zhoushan City, with an average annual incidence of 5.36‰. The incidences for each year were 5.78‰, 5.29‰ and 5.02‰, respectively, and the outpatient proportions were 0.15%, 0.14% and 0.11%, respectively, showed decreasing trends (both P<0.05). The number of doses of recombinant herpes zoster vaccine or live attenuated herpes zoster vaccine administered were 130, 312, and 633, respectively. The main consultation department was dermatology, with 11 004 cases (72.60%). The primary clinical diagnosis was visceral herpes zoster, with 5 901 cases (38.94%). A total of 1 936 cases (12.77%) had at least one underlying medical condition. The mean age of onset was (56.08±16.23) years, and the incidence showed an upward trend with increasing age (P<0.05). There were 7 386 male cases and 7 770 female cases, with a male-to-female ratio of 0.95∶1. The incidence among males aged ≥50 years was lower than that among females (6.53‰ vs. 8.69‰, P<0.05). The onset of the disease exhibited a significant seasonal pattern, with a peak period from June 21st to August 21st, covering 75% of the cases. Conclusions From 2021 to 2023, the incidence and outpatient proportion of herpes zoster in Zhoushan City decreased. Summer was the peak season for onset, and women and the elderly were the key populations. It is necessary to strengthen the collaborative diagnostic and treatment capabilities of key departments such as dermatology and enhance the enthusiasm for vaccination among key populations.
Key wordsherpes zoster    incidence    vaccination
收稿日期: 2024-12-26      修回日期: 2025-06-06      出版日期: 2025-07-10
中图分类号:  R181.3  
作者简介: 冷雪,本科,主治医师,主要从事传染性疾病预防与控制工作
通信作者: 谭启龙,E-mail:339550466@qq.com   
引用本文:   
冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
LENG Xue, FU Shuqin, SHU Jiwei, TAN Qilong, LI Kefeng. Characteristics of the first-visit cases of herpes zoster in Zhoushan City. Preventive Medicine, 2025, 37(7): 701-704.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.07.012      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I7/701
[1] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组,国家皮肤与免疫疾病临床医学研究中心.中国带状疱疹诊疗专家共识(2022版)[J].中华皮肤科杂志,2022,55(12):1033-1040.
Consensus Workgroup on Herpes Zoster,China Dermatologist Association,National Clinical Research Center for Skin and Immune Diseases.Chinese consensus on the diagnosis and management of herpes zoster(2022)[J].Chin J Dermatol,2022,55(12):1033–1040.(in Chinese)
[2] PATIL A,GOLDUST M,WOLLINA U.Herpes zoster:a review of clinical manifestations and management[J/OL].Viruses,2022,14(2)[2025-06-06].https://doi.org/10.3390/v14020192.
[3] LI Y,AN Z J,YIN D P,et al.Disease burden due to herpes zoster among population aged ≥50 years old in China:a community based retrospective survey[J/OL].PLoS One,2016,11(4)[2025-06-06].https://doi.org/10.1371/journal.pone.0152660.
[4] 张娇,郭晓璟,李书明,等.北京市朝阳区≥50岁慢性病患者带状疱疹疫苗接种率和接种意愿[J].中国疫苗和免疫,2023,29(6):687-693.
ZHANG J,GUO X J,LI S M,et al.Herpes zoster vaccine coverage and willingness to receive the vaccine among ≥50-year-old patients with chronic diseases in Chaoyang district of Beijing[J].Chin J Vaccines Immunization,2023,29(6):687-693.(in Chinese)
[5] 王静,叶冬青.圆分布分析方法及实例应用[J].疾病控制杂志,2004,8(2):160-161.
WANG J,YE D Q.The circular distribution analysis and application[J].Chin J Dis Control Prev,2004,8(2):160-161.(in Chinese)
[6] 朱宗龙,杨俊英,许颖.2021年北京市昌平区带状疱疹首次就诊病例流行病学特征分析[J].疾病预防控制通报,2023,38(6):50-53.
ZHU Z L,YANG J Y,XU Y.Analysis of epidemiological characteristics of first visit patients with herpes zoster in Changping district of Beijing,2021[J].Bull Dis Control Prev Dec,2023,38(6):50-53.(in Chinese)
[7] 罗秀兰,郑永韬,倪梦姣,等.一起带状疱疹病例引起的医院水痘暴发疫情调查[J].预防医学,2025,37(5):490-493.
LUO X L,ZHENG Y T,NI M J,et al.Epidemiological investigation of a nosocomial varicella outbreak triggered by a herpes zoster case[J].China Prev Med J,2025,37(5):490-493.(in Chinese)
[8] 刘娜,栾琳,张钧,等.带状疱疹的临床和流行病学特征综述[J].中国疫苗和免疫,2023,29(1):102-112.
LIU N,LUAN L,ZHANG J,et al.Clinical and epidemiological characteristics of herpes zoster:a literature review[J].Chin J Vaccines Immunization,2023,29(1):102-112.(in Chinese)
[9] 王敏,高静,冯玫.常见慢性病与带状疱疹相关性的研究进展[J].中华全科医师杂志,2024,23(4):419-424.
WANG M,GAO J,FENG M.Research progress on association between chronic diseases and herpes zoster[J].Chin J Gen Pract,2024,23(4):419-424.(in Chinese)
[10] GROSS G E,EISERT L,DOERR H W,et al.S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia[J].J Dtsch Dermatol Ges,2020,18(1):55-78.
[11] MUÑOZ-QUILES C,LÓPEZ-LACORT M,AMPUDIA-BLASCO F J,et al.Risk and impact of herpes zoster on patients with diabetes:a population-based study,2009-2014[J].Hum Vaccin Immunother,2017,13(11):2606-2611.
[12] KAWAI K,YAWN B P.Risk factors for herpes zoster:a systematic review and meta-analysis[J].Mayo Clin Proc,2017,92(12):1806-1821.
[13] KAWAI K,VOPHAM T,DRUCKER A,et al.Ultraviolet ra-diation exposure and the risk of herpes zoster in three pro-spective cohort studies[J].Mayo Clin Proc,2020,95(2):283-292.
[1] 罗秀兰, 郑永韬, 倪梦姣, 鲁潮, 徐婷燕, 翁绩燕, 来芬华. 一起带状疱疹病例引起的医院水痘暴发疫情调查[J]. 预防医学, 2025, 37(5): 490-493.
[2] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[3] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[4] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[5] 陈家烨, 胡昱. 浙江省社区卫生服务中心预防接种人员流动性调查[J]. 预防医学, 2025, 37(5): 536-540.
[6] 张超, 沈建勇, 罗小福, 刘艳, 韩利萍. 2007—2023年湖州市流行性乙型脑炎流行特征[J]. 预防医学, 2025, 37(4): 386-389.
[7] 张小乔, 张筱碟, 赵振希, 谢鹏留, 代敏. LSTM、SARIMA和SARIMAX模型预测手足口病发病率的效果比较[J]. 预防医学, 2025, 37(3): 280-284,287.
[8] 沈敏, 郁智慧, 朱爱韬. 1992—2021年中国慢性阻塞性肺疾病发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2025, 37(2): 113-117.
[9] 赵琳, 蒋龙艳, 徐斌, 唐咸艳. 南宁市五种主要恶性肿瘤发病率分析[J]. 预防医学, 2025, 37(2): 135-138.
[10] 裘凤黔, 赵俊峰, 陈玮华, 杜娟, 纪云芳, 高淑娜, 蒙洁, 何丽华, 陈博, 张艳. 2002—2019年黄浦区肺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(2): 143-147.
[11] 李依窈, 李小菊, 申小颖, 张宪琦, 赵莉, 张玉涵, 汪欣梦. 老年人接种流行性感冒疫苗的影响因素分析[J]. 预防医学, 2025, 37(1): 31-35.
[12] 章群, 王永, 陈洁平, 包凯芳, 冯玥溢, 王小丽. 2011—2023年宁波市前列腺癌发病和死亡趋势分析[J]. 预防医学, 2025, 37(1): 46-50.
[13] 杨旭, 王旭雯. 2015—2023年无锡市风疹流行特征[J]. 预防医学, 2025, 37(1): 65-68.
[14] 周国营, 邢丽丽, 苏颖, 刘宏杰, 刘赫, 王迪, 薛锦峰, 戴威, 汪静, 杨兴华. 2007—2022年东城区心血管疾病发病趋势[J]. 预防医学, 2024, 36(9): 813-816.
[15] 赵棋锋, 王吉玲, 马岩, 方益荣. 2005—2023年绍兴市布鲁氏菌病流行特征分析[J]. 预防医学, 2024, 36(9): 806-808,812.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed